Up next

Attention

Are you paying attention when you scroll online? In episode 176 of Overthink, Ellie and David draw your attention to attention. They explain why attention is so hard to define and debate the extent to which it should be equated with consciousness. Is attention the same thing as c ...  Show more

Coolness

Play it cool and play this episode. In episode 175 of Overthink, Ellie and David talk about what it means to be cool. From swag gap relationships to Mark Zuckerberg and the manosphere’s failed attempts at being cool, your hosts examine coolness’s ties to youth and subversion and ...  Show more

Recommended Episodes

psychedelic therapy, a talk with robin carhart-harris [video]
anything goes with emma chamberlain

[video available on spotify] i've dabbled in the world of psychedelics a little bit. i've taken mushrooms a few times, but i really don't know a lot about psychedelics. however, it's becoming an increasingly more relevant topic as it's been revealed that they can help with mental ...  Show more

Michael Pollan on the New Science of Psychedelics and Consciousness
The One You Feed | Personal Growth, Emotional Resilience & Purpose

Michael Pollan is a writer whose books have topped the New York Times bestseller list time and time again. He teaches writing at Harvard and The University of California Berkley. In 2010, Time magazine name Michael Pollan one of the most influential people in the world. His books ...  Show more

Psychedelic-Assisted Therapy with Dr. Albert Garcia Romeu
Being Well with Forrest Hanson and Dr. Rick Hanson

There’s been an explosion of interest in psychedelics over the last 10 years, and phrases like “psychedelic-assisted therapy” have gone from the relative fringes of the mental health conversation to bursting into the mainstream. Alongside a great deal of hype is a growing body of ...  Show more

#306 — Psychedelics & Mortality
Making Sense with Sam Harris

<span style="font-weight: 400;">Sam Harris speaks with Roland Griffiths about psychedelics and mortality. They discuss the current state of psychedelic research, the timeline for FDA approvals, the risks to mental health posed by psychedelics in vulnerable populations, the use ...

  Show more